EZH2 and neoplasm: miR-101 inhibits angiogenesis by targeting enhancer of zeste homolog 2 in tumor tissues [58, 59].Contrarily, Kim et al. found that miR-101 upregulates HO-1 and VEGF by targeting the Cullin 3 protein under hypoxic conditions, thereby promoting angiogenesis [10].